The NFKBIA expression level was significantly (p < 0.001) higher in the normal than in the cancer tissue in LUAD, LUSC, UCEC, and COAD patients; however, it was significantly (p < 0.01) higher in the tumor than the normal tissue in GBM patients. This evidence concerns the gene NFKBIA and glioblastoma.